A Cost-Effectiveness Analysis of Axitinib and Sorafenib for...

A Cost-Effectiveness Analysis of Axitinib and Sorafenib for 2nd Line Treatment of Advanced Renal Cell Carcinoma After Failure of Cytokines in the United States

Stillman, I.O., Ambavane, A., Cislo, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2013.08.500
Date:
November, 2013
File:
PDF, 61 KB
english, 2013
Conversion to is in progress
Conversion to is failed